PTPA and acute myeloid leukemia: Like Gally et al. (33), they found that PP2A activity was reduced in AML patient samples and suppressed activity of the protein phosphatase likely involved multiple mechanisms including phosphorylation of the C subunit, inhibition by SET or CIP2A, or dysregulation of subunit expression (35).